AV

Altos Venture

Europe, Basel-Landschaft, Switzerland, Allschwil

Description

Altos Venture is a venture capital firm that specializes in seed/start-up investments.

Investor Profile

Altos Venture has made 4 investments, with 0 in the past 12 months and 75% as lead.

Stage Focus

  • Series A (25%)
  • Series Unknown (25%)
  • Series B (25%)
  • Series D (25%)

Country Focus

  • Switzerland (75%)
  • South Korea (25%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Consumer Goods
  • E-commerce
  • Marketplace
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Altos Venture frequently co-invest with?

Mirae Asset Capital
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Co-Investments: 1
Zürcher Kantonal Bank
Europe, Zurich, Switzerland, Zürich
Co-Investments: 3
Smilegate Investment
Asia, Kyonggi-do, South Korea, Seongnam
Co-Investments: 1
Mirae Asset Venture Investment
Asia, Kyonggi-do, South Korea, Seongnam
Co-Investments: 1
IMM Investment
Asia, Cholla-namdo, South Korea, Kangnam
Co-Investments: 1
GlobalBrain
Oceania, Canterbury, New Zealand, Christchurch
Co-Investments: 1
Stone Bridge Ventures
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1

Which angels does Altos Venture often collaborate with?

Shared Deals: 1

What are some of recent deals done by Altos Venture?

IDUS

Mapo, Seoul-t'ukpyolsi, South Korea

IDUS is an online marketplace for consumer goods.

Consumer GoodsE-CommerceMarketplace
Series DJun 8, 2020
Amount Raised: $25,084,451
ProteoMediX

Schlieren, Zurich, Switzerland

ProteoMediX is a spinoff company of ETH Zurich and specialized in the identification of novel biomarkers for the early detection of cancer.

BiotechnologyHealth CareMedical
Series UnknownAug 27, 2018
Amount Raised: $5,309,200
ProteoMediX

Schlieren, Zurich, Switzerland

ProteoMediX is a spinoff company of ETH Zurich and specialized in the identification of novel biomarkers for the early detection of cancer.

BiotechnologyHealth CareMedical
Series BApr 9, 2014
Amount Raised: $3,632,801
ProteoMediX

Schlieren, Zurich, Switzerland

ProteoMediX is a spinoff company of ETH Zurich and specialized in the identification of novel biomarkers for the early detection of cancer.

BiotechnologyHealth CareMedical
Series AJan 12, 2012
Amount Raised: $2,746,321